The global vascular grafts market size was valued at USD 1.61 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028; reaching US$ 2.75 billion in 2028. Vascular graft is a surgical procedure which is performed to redirect blood flow from one area to other by reconnecting blood vessels. It is carried to bypass around an infected artery from a range of ordinary bloodstream to another moderate normal region. It is usually performed when there is scarce blood supply to the body caused by atherosclerosis as a part of organ transplant.
Vascular diseases have high worldwide mortality, propelling advances in endovascular surgeries. Developing effective and long-term revascularization solutions has gathered immense attention among healthcare providers. Main cause responsible for vascular graft is coronary heart diseases, peripheral artery diseases (PAD) and cerebrovascular disease. According to Center for Disease Control and Prevention, coronary heart disease is the frequent heart disease with 370,000 casualties annually in the US alone. Every year, the UN reports 17.9 million people who die from cardiovascular disease worldwide. Broad R&D activities in vascular graft, increase in cases of vascular disorders, hypertension, high blood sugar level, high cases of cardiovascular diseases, peripheral diseases and rise in geriatric population and increase in government investment towards health care infrastructure are expected to drive the global vascular graft market. North America dominates vascular graft market due to high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. Presence of reimbursement facility and availability of healthcare infrastructure are driving the growth of this market in North America. Asia-Pacific is expected to show the fastest growth due to increasing incidences of cardiovascular disease and diabetes and improving healthcare infrastructure.
Vascular Grafts Market is categorized in terms of product, source, size, end user and region. On the basis of product, it is segmented into endovascular stent grafts, hemodialysis access grafts, bypass grafts, peripheral vascular grafts, and others. By source, it is segmented into synthetic, biological, and biosynthetic. By size, it is segmented into large and small. On the basis of end-user, it is divided into hospitals, ambulatory surgery centers, cardiac catheterization laboratories, specialty clinics, and others. On the basis of region, it is segmented into North America (USA and Canada), Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia Pacific (India, China, Australia, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East & Africa.
The prominent players in the global vascular grafts market are W. L. Gore & Associates, Inc., Maquet Holding B.V. & Co. KG (Getinge Group), BD, LeMaitre Vascular, Inc., B. Braun Melsungen AG, Cook Medical, Medtronic plc, Artegraft, Inc., Vascutek Ltd., Vascular Graft Solution Ltd., Heat Medical Europe BV, and CryoLife, Inc among others.
Segmentation and Scope of the Global Vascular Grafts Market
Vascular Grafts Market is segmented into product, source, size, end user and region.
The prominent players involved in the global vascular grafts market are,